Last Updated: August 9, 2026

Suppliers and packagers for FIORICET W/ CODEINE


✉ Email this page to a colleague

« Back to Dashboard


FIORICET W/ CODEINE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Actavis Labs Ut Inc FIORICET W/ CODEINE acetaminophen; butalbital; caffeine; codeine phosphate CAPSULE;ORAL 020232 NDA AUTHORIZED GENERIC Actavis Pharma, Inc. 0591-3220-01 100 CAPSULE in 1 BOTTLE (0591-3220-01) 2003-09-18
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

FIORICET W/ CODEINE Suppliers (API, Finished Dose, and Contract Packaging) — What to Source and Who Supplies the Drug

Last updated: June 25, 2026

Which companies supply Fioricet w/ codeine (butalbital, acetaminophen, caffeine, codeine) finished drug product?

No complete, accurate supplier roster is available from the provided inputs. If the supplier list is restricted to verifiable public records (e.g., FDA Orange Book “Manufactured for” / labeler data, Drug Product listings, and distribution chain disclosures), the necessary identifiers for “Fioricet w/ codeine” (exact NDA, strength, dosage form, and labeler/manufacturer names) are not included here, so a supplier table cannot be produced without risking factual errors.

What API suppliers make butalbital, acetaminophen, caffeine, and codeine for Fioricet w/ codeine?

No complete, accurate API supplier mapping is available from the provided inputs. A correct API supply analysis requires confirmed API grade source attribution for each active ingredient (butalbital, acetaminophen, caffeine, codeine) tied to the specific drug product via NDA/ANDA manufacturing controls or supplier-of-record disclosures.

How do you identify Fioricet w/ codeine manufacturers and distributors in the FDA Orange Book and Drug Product database?

No extractable Orange Book dataset is available from the provided inputs. A defensible manufacturer/distributor list depends on:

  • the exact product listing (NDA number, strength, dosage form, and route),
  • the Orange Book labeler/manufacturer fields, and
  • the Drug Registration and Listing System (DRLS) and DailyMed “Manufactured for” labeler.

Which contract manufacturers produce Fioricet w/ codeine (tablet) for major labelers?

No complete, accurate contract manufacturing identification is available from the provided inputs. Contract manufacturing attribution requires public proof from labeler/manufacturer fields, inspection outcomes tied to the NDA, or facility-level disclosures in FDA records linked to the product’s NDA.

What packaging and labeling suppliers support Fioricet w/ codeine distribution?

No complete, accurate packaging and labeling supplier roster is available from the provided inputs. Packaging supplier identification requires DRLS facility links, labeler details, or facility-level quality system references tied to the product’s registration.

How many supply-chain nodes exist for Fioricet w/ codeine (API, granulation, tablet compression, coating, bottling)?

No quantified supply-chain node map is available from the provided inputs. A node-count requires confirmed manufacturing sites for the specific NDA product line.


Key Takeaways

  • A verified supplier list for FIORICET W/ CODEINE cannot be produced from the provided information.
  • High-stakes supplier attribution requires a specific FDA product listing identifier (NDA + strength + dosage form) and corresponding public manufacturer/labeler fields.

FAQs

  1. How do I find the NDA labeler and manufacturer for Fioricet w/ codeine?
  2. Who typically supplies butalbital and codeine APIs for combination products?
  3. What FDA listings show the manufacturing site for Fioricet w/ codeine tablets?
  4. How do contract manufacturers get credited on DailyMed or Orange Book labeler fields?
  5. What records identify bottle labeling and packaging suppliers for controlled-substance combination products?

References

No sources were cited because no supplier-identifying dataset (Orange Book/DRLS/DailyMed/NDA identifiers) was provided in the prompt.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.